TELADOC HEALTH, INC. Proceeds from Sale and Maturity of Marketable Securities
TELADOC HEALTH, INC. (TDOC) reported Proceeds from Sale and Maturity of Marketable Securities of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2025-02-27
- TELADOC HEALTH, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2023-12-31 was $0.00.
- TELADOC HEALTH, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2022-12-31 was $0.00.
- TELADOC HEALTH, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2022-09-30 was $2.51M.
- TELADOC HEALTH, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2022-06-30 was $0.00.
- TELADOC HEALTH, INC. proceeds from sale and maturity of marketable securities for fiscal 2024 was $0.00.
- TELADOC HEALTH, INC. proceeds from sale and maturity of marketable securities for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- TELADOC HEALTH, INC. proceeds from sale and maturity of marketable securities for fiscal 2022 was $2.51M, a 94.99% decline from fiscal 2021.
- TELADOC HEALTH, INC. proceeds from sale and maturity of marketable securities for fiscal 2021 was $50.00M, a 1903.21% increase from fiscal 2020.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-10-27 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.51M derived: sum of 2 quarters · filed 2025-02-27 | $2.51M derived: sum of 3 quarters · filed 2025-02-27 | $2.51M 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $2.51M derived: sum of 2 quarters · filed 2023-10-27 | $2.51M 10-Q · filed 2023-10-27 | $2.51M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | $0.00 derived: sum of 3 quarters · filed 2024-02-23 | $0.00 derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-02 | $0.00 derived: sum of 2 quarters · filed 2024-02-23 | $0.00 derived: sum of 3 quarters · filed 2024-02-23 | $0.00 derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $0.00 derived: sum of 2 quarters · filed 2024-02-23 | $0.00 derived: sum of 3 quarters · filed 2024-02-23 | $50.00M 10-K · filed 2024-02-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $50.00M 10-Q · filed 2022-11-02 | $52.50M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $50.00M 10-Q · filed 2022-08-03 | $52.50M derived: sum of 3 quarters · filed 2023-03-01 | $52.50M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $50.00M 10-Q · filed 2022-05-02 | $52.50M derived: sum of 2 quarters · filed 2023-03-01 | $52.50M derived: sum of 3 quarters · filed 2023-03-01 | $52.50M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.50M derived: sum of 2 quarters · filed 2023-03-01 | $2.50M derived: sum of 3 quarters · filed 2023-03-01 | $2.50M 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $0.00 derived: sum of 2 quarters · filed 2021-11-01 | $0.00 10-Q · filed 2021-11-01 | $12.94M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $0.00 10-Q · filed 2021-08-02 | $12.94M derived: sum of 3 quarters · filed 2022-02-28 | $29.41M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-03 | $12.94M derived: sum of 2 quarters · filed 2022-02-28 | $29.41M derived: sum of 3 quarters · filed 2022-02-28 | $43.10M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $12.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $29.41M derived: sum of 2 quarters · filed 2022-02-28 | $43.10M derived: sum of 3 quarters · filed 2022-02-28 | $52.10M 10-K · filed 2022-02-28 |
| 2019-09-30 | $16.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $30.16M derived: sum of 2 quarters · filed 2020-11-06 | $39.16M 10-Q · filed 2020-11-06 | $43.87M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $13.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $22.70M 10-Q · filed 2020-07-29 | $27.39M derived: sum of 3 quarters · filed 2021-03-01 | $38.90M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $9.00M 10-Q · filed 2020-04-29 | $13.70M derived: sum of 2 quarters · filed 2021-03-01 | $25.20M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $16.20M derived: sum of 2 quarters · filed 2021-03-01 | $84.17M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $11.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $79.47M 10-Q · filed 2019-10-30 | ||
| 2018-06-30 | $67.97M 10-Q · filed 2019-07-31 | |||
| 2017-12-31 | $85.75M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |